{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:40:37Z","timestamp":1778697637027,"version":"3.51.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/fbp.0b013e32833e7f2a","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T12:31:47Z","timestamp":1282307507000},"page":"668-675","source":"Crossref","is-referenced-by-count":17,"title":["Metabolic and behavioral effects of chronic olanzapine treatment and cafeteria diet in rats"],"prefix":"10.1097","volume":"21","author":[{"given":"Alexandre P.","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana H.","family":"Tort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juss\u00e2nia","family":"Gnoatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia D.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa R.","family":"Vinad\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos L.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo O.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo R.","family":"Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis V.","family":"Portela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210202","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R2-10-20210202","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S0033291798008186","article-title":"The unhealthy lifestyle of people with schizophrenia","volume":"29","author":"Brown","year":"1999","journal-title":"Psychol Med"},{"issue":"2","key":"R3-10-20210202","first-page":"15S","article-title":"Metabolic issues and cardiovascular disease in patients with psychiatric disorders","volume":"118","author":"Casey","year":"2005","journal-title":"Am J Med"},{"issue":"7","key":"R4-10-20210202","first-page":"4","article-title":"The pharmacology of weight gain with antipsychotics","volume":"62","author":"Casey","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R5-10-20210202","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/jn\/136.10.2475","article-title":"Glyceroneogenesis is reduced and glucose uptake is increased in adipose tissue from cafeteria diet-fed rats independently of tissue sympathetic innervation","volume":"136","author":"Chaves","year":"2006","journal-title":"J Nutr"},{"key":"R6-10-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2008.06.006","article-title":"Insulin resistance following continuous, chronic olanzapine treatment: an animal model","volume":"104","author":"Chintoh","year":"2008","journal-title":"Schizophr Res"},{"key":"R7-10-20210202","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00213-005-2224-4","article-title":"A parametric analysis of olanzapine-induced weight gain in female rats","volume":"181","author":"Cooper","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R8-10-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/0269881106069637","article-title":"Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities","volume":"21","author":"Cooper","year":"2007","journal-title":"J Psychopharmacol"},{"key":"R9-10-20210202","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pnpbp.2007.09.012","article-title":"Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain","volume":"32","author":"Cooper","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R10-10-20210202","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/0269881105053284","article-title":"Cinnarizine has an atypical antipsychotic profile in animal models of psychosis","volume":"19","author":"Dall'Igna","year":"2005","journal-title":"J Psychopharmacol"},{"key":"R11-10-20210202","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2006.05.021","article-title":"Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment","volume":"542","author":"Didriksen","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R12-10-20210202","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12017-007-8011-0","article-title":"Western style diet impairs entrance of blood-borne insulin-like growth factor-1 into the brain","volume":"9","author":"Dietrich","year":"2007","journal-title":"Neuromolecular Med"},{"key":"R13-10-20210202","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pnpbp.2007.10.001","article-title":"Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats","volume":"32","author":"Egashira","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R14-10-20210202","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0306-4530(02)00049-5","article-title":"Olanzapine's effects to reduce fear and anxiety and enhance social interactions coincide with increased progestin concentrations of ovariectomized rats","volume":"28","author":"Frye","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"R15-10-20210202","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/0269881107082904","article-title":"Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications","volume":"22","author":"Goudie","year":"2008","journal-title":"J Psychopharmacol"},{"key":"R16-10-20210202","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/FBP.0b013e328014138d","article-title":"Olanzapine and JL13 induce cross-tolerance to the clozapine discriminative stimulus in rats","volume":"18","author":"Goudie","year":"2007","journal-title":"Behav Pharmacol"},{"key":"R17-10-20210202","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","article-title":"Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \u2018right stuff\u2019?","volume":"26","author":"Green","year":"2000","journal-title":"Schizophr Bull"},{"issue":"3","key":"R18-10-20210202","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.euroneuro.2006.06.003","article-title":"Differential metabolic effects of antipsychotic treatments","volume":"16","author":"Haupt","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"R19-10-20210202","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1639-8","article-title":"Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors","volume":"207","author":"Kirk","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"R20-10-20210202","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"R21-10-20210202","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2008.04.017","article-title":"Olanzapine counteracts stress-induced anxiety-like behavior in rats","volume":"438","author":"Locchi","year":"2008","journal-title":"Neurosci Lett"},{"key":"R22-10-20210202","first-page":"534","article-title":"Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study","volume":"183","author":"McCreadie","year":"2003","journal-title":"Br J Psychiatry"},{"key":"R23-10-20210202","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.pbb.2008.04.014","article-title":"Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: contrast with haloperidol and chlordiazepoxide","volume":"90","author":"Mead","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"R24-10-20210202","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbr.2005.05.004","article-title":"Effects of chronic neuroleptic treatments on nutrient selection, body weight, and body composition in the male rat under dietary self-selection","volume":"163","author":"Minet-Ringuet","year":"2005","journal-title":"Behav Brain Res"},{"key":"R25-10-20210202","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-006-0433-0","article-title":"A model for antipsychotic-induced obesity in the male rat","volume":"187","author":"Minet-Ringuet","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R26-10-20210202","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0306-4522(02)00123-9","article-title":"A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning","volume":"112","author":"Molteni","year":"2002","journal-title":"Neuroscience"},{"key":"R27-10-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neuroscience.2003.09.020","article-title":"Exercise reverses the harmful effects of consumption of a high-fat diet on synaptic and behavioral plasticity associated to the action of brain-derived neurotrophic factor","volume":"123","author":"Molteni","year":"2004","journal-title":"Neuroscience"},{"key":"R28-10-20210202","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s11064-007-9530-7","article-title":"Different effect of high fat diet and physical exercise in the hippocampal signaling","volume":"33","author":"Muller","year":"2008","journal-title":"Neurochem Res"},{"issue":"18","key":"R29-10-20210202","first-page":"36","article-title":"Abnormalities of glucose metabolism associated with atypical antipsychotic drugs","volume":"65","author":"Newcomer","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R30-10-20210202","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"R31-10-20210202","first-page":"S170","article-title":"Metabolic syndrome and mental illness","volume":"13","author":"Newcomer","year":"2007","journal-title":"Am J Manag Care"},{"key":"R32-10-20210202","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archpsyc.59.4.337","article-title":"Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia","volume":"59","author":"Newcomer","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R33-10-20210202","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0026-0495(98)90283-9","article-title":"Reversal of diet-induced obesity and diabetes in C57BL\/6J mice","volume":"47","author":"Parekh","year":"1998","journal-title":"Metabolism"},{"key":"R34-10-20210202","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1471-4159.2004.02920.x","article-title":"The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern","volume":"92","author":"Rauggi","year":"2005","journal-title":"J Neurochem"},{"key":"R35-10-20210202","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5416-06.2007","article-title":"\u2018Breakthrough\u2019 dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time","volume":"27","author":"Samaha","year":"2007","journal-title":"J Neurosci"},{"key":"R36-10-20210202","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lfs.2007.05.001","article-title":"Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior","volume":"81","author":"Souza","year":"2007","journal-title":"Life Sci"},{"key":"R37-10-20210202","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2007.06.012","article-title":"Morris water maze learning in Long-Evans rats is differentially affected by blockade of D1-like and D2-like dopamine receptors","volume":"422","author":"Stuchlik","year":"2007","journal-title":"Neurosci Lett"},{"key":"R38-10-20210202","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00213-002-1230-z","article-title":"Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats","volume":"164","author":"Terry","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"R39-10-20210202","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.neuroscience.2008.08.030","article-title":"Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats","volume":"156","author":"Terry","year":"2008","journal-title":"Neuroscience"},{"key":"R40-10-20210202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneumeth.2006.04.005","article-title":"A simple webcam-based approach for the measurement of rodent locomotion and other behavioural parameters","volume":"157","author":"Tort","year":"2006","journal-title":"J Neurosci Methods"},{"key":"R41-10-20210202","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/01.ATV.21.6.881","article-title":"Is visceral adiposity the \u2018enemy within\u2019?","volume":"21","author":"Tracy","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R42-10-20210202","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diab.15.3.164","article-title":"A survey for unknown diabetics in a mental hospital. II. Men from age fifty","volume":"15","author":"Waitzkin","year":"1966","journal-title":"Diabetes"},{"key":"R43-10-20210202","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s002130050834","article-title":"The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors","volume":"141","author":"Zhang","year":"1999","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008877-201010000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T20:59:46Z","timestamp":1740430786000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201010000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0b013e32833e7f2a","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}